NMRA
Neumora Therapeutics Inc.
$2.19
+$0.06(+2.58%)
45
Overall
60
Value
30
Tech
--
Quality
Market Cap
$432.76M
Volume
845.85K
52W Range
$0.61 - $3.65
Target Price
$9.14
EPS Estimates Overview
| Current Quarter | $-0.32 | Next Quarter | $-0.25 |
| Current Year | $-0.99 | Next Year | $-0.91 |
| QoQ Growth | +21.9% | YoY Growth | +8.1% |
| 3Y EPS CAGR | N/A | Target Price | $9.14 |
| Consensus | Buy | Upside | +318.3% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NMRA | $2.19 | +2.6% | 845.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neumora Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW